secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProMIS Neurosciences Inc. (PMN)
CIK:        0001374339
Form:       8-K
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001104659-23-094126
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProMIS Neurosciences raises $20.4M in PIPE financing to fund clinical development
--------------------------------------------------------------------------------

- Gross proceeds of ~$20.4M from sale of common share units at $1.88/unit and pre-funded units at $1.87/unit.
- Participation from Affinity Asset Advisors, Ally Bridge Group, Sphera Healthcare and other accredited investors.
- Proceeds to advance clinical development of PMN310, lead therapeutic candidate, and for working capital.
- Insiders (directors and officers) subscribing for ~$145,000 of units under related party transaction exemptions.
- Financing expected to close on August 23, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374339/000110465923094126/0001104659-23-094126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374339/000110465923094126/tm2324315d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-094126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer